Comparative efficacy and safety of ivermectin cream 1% and metronidazole cream 0.75% in the treatment of papulopustular rosacea

被引：0
|
作者：
Taieb, Alain [1 ]
Ruzicka, Thomas [2 ]
Berth-Jones, John [3 ]
Peirone, Marie-Helene [4 ]
Jacovella, Jean [4 ]
机构：
[1] Hop St Andre, Serv Dermatol, Bordeaux, France
[2] Univ Munich, Dept Dermatol & Allergy, Munich, Germany
[3] Dept Dermatol, Dermatol Clin Res Unit, Nuneaton, Warwick, England
[4] Galderma Res & Dev SNC, Sophia Antipolis, France
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2015年 / 72卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
1158
引用
收藏
页码：AB6 / AB6
页数：1
相关论文
共 50 条
  • [1] Comparative efficacy and safety of ivermectin 1% cream and metronidazole 0.75% cream in the novel treatment of papulopustular rosacea: The ATTRACT (assessment of a topical treatment in rosacea - activity, compliance, tolerability) study
    Foley, P.
    Taieb, A.
    Ruzicka, T.
    Peirone, M. H.
    Jacovella, J.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2016, 57 : 33 - 33
  • [2] Efficacy of 1% terbinafine cream in comparison with 0.75% metronidazole gel for the treatment of papulopustular rosacea
    Serdar, Zehra Asiran
    Yasar, Sirin
    CUTANEOUS AND OCULAR TOXICOLOGY, 2011, 30 (02) : 124 - 128
  • [3] A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea
    Maddin, S
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (06) : 961 - 965
  • [4] Maintenance of remission following successful treatment of papulopustular rosacea with ivermectin 1% cream vs. metronidazole 0.75% cream: 36-week extension of the ATTRACT randomized study
    Taieb, A.
    Khemis, A.
    Ruzicka, T.
    Baranska-Rybak, W.
    Berth-Jones, J.
    Schauber, J.
    Briantais, P.
    Jacovella, J.
    Passeron, T.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (05) : 829 - 836
  • [5] Superior Efficacy with Ivermectin 1% Cream Compared to Metronidazole 0.75% Cream Contributes to a Better Quality of Life in Patients with Severe Papulopustular Rosacea: A Subanalysis of the Randomized, Investigator-Blinded ATTRACT Study
    Martin Schaller
    Thomas Dirschka
    Lajos Kemény
    Philippe Briantais
    Jean Jacovella
    Dermatology and Therapy, 2016, 6 : 427 - 436
  • [6] Superior Efficacy with Ivermectin 1% Cream Compared to Metronidazole 0.75% Cream Contributes to a Better Quality of Life in Patients with Severe Papulopustular Rosacea: A Subanalysis of the Randomized, Investigator-Blinded ATTRACT Study
    Schaller, Martin
    Dirschka, Thomas
    Kemeny, Lajos
    Briantais, Philippe
    Jacovella, Jean
    DERMATOLOGY AND THERAPY, 2016, 6 (03) : 427 - 436
  • [7] Ivermectin 1% Cream, an effective and safe topical treatment of inflammatory lesions of papulopustular rosacea
    Foley, P.
    Stein-Gold, L.
    Kircik, L.
    Fowler, J.
    Jackson, M.
    Tan, J.
    Draleos, Z.
    Fleischer, A.
    Appell, M.
    Steinhoff, M.
    Lynde, C.
    Hong, L.
    Jacovella, J.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2016, 57 : 32 - 32
  • [8] Ivermectin cream in rosacea: comparison with metronidazole gel
    Loo, WJ
    Ayyalaraju, S
    Chawla, M
    Finlay, AY
    Coles, EC
    Marks, R
    BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 : 61 - 61
  • [9] Superiority of ivermectin 1% cream over metronidazole 0.75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial
    Taieb, A.
    Ortonne, J. P.
    Ruzicka, T.
    Roszkiewicz, J.
    Berth-Jones, J.
    Peirone, M. H.
    Jacovella, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (04) : 1103 - 1110
  • [10] A comparison of metronidazole 1% cream and pimecrolimus 1% cream in the treatment of patients with papulopustular rosacea: a randomized open-label clinical trial
    Koca, R.
    Altinyazar, H. C.
    Ankarali, H.
    Muhtar, S.
    Tekin, N. S.
    Cinar, S.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2010, 35 (03) : 251 - 256
12345